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up and down three times: 29.6 s (SD 12.5 s) and walking 50
m: 34.4 s (SD 8.7 s); standing balance showed a total mean
for all three groups of average angular velocity: 1.3 m ·s-1 (SD
0.3 m ·s-1), per cent maximum stability: 65.3 (SD 10.9) and per
cent ankle strategy: 70.4 (SD 10.3); isometric muscle strength
showed a total mean for all three groups of knee extension: 72.3
Nm (SD 25.6 Nm) and knee flexion: 37.5 Nm (SD 12.6 Nm).
Conclusions: Preliminary results indicates that WBV may affect
the muscle function and balance in patients with knee OA. How-
ever, analysis is in progress, and the final results and conclusions
will be presented at the congress.
Pain and Disability
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Purpose: Significant risk factors in development of knee os-
teoarthritis (OA) has shown to be quadriceps weakness, joint
instability, and changes in joint loading. Few studies have looked
at these risk factors for hip OA. Furthermore, very few studies,
have reported biomechanical changes in gait patterns affecting
joint loading. There are no studies so far describing both biome-
chanics during gait (joint loading) and clinical outcomes in hip OA
patients. The purpose of this study was to identify biomechanical
and clinical characteristics among patients with hip OA.
Methods: Fifty patients aged 60.0 (±10.3) years, 32 women
and 18 men, with hip pain >3months, activity limitations, and
radiographically verified hip OA were included consecutively.
Gait analysis was performed using Qualisys Pro reflex 3D mo-
tion analysis system, including three forceplates (AMTI). Fur-
thermore, the disease specific questionnaire,WOMAC, isokinetic
muscle strength (TechnoRev9000), sub-maximal cardiovascular
function (Åstrand’s bike-test), hip range of motion, and 6 minute
walk test, the generic health-related quality of life questionnaire
(SF-36v2), self-efficacy for pain, and the physical activity scale
for the elderly, PASE, were included.
Results: The WOMAC showed a mean total score of 25.9
(±15.4) mm, 26.9 (±17.3) mm for pain, 34.4 (±21.5) mm for
stiffness, and 24.6 (±15.7) mm for physical function subscales.
There was a significant decrease in peak isokinetic muscle
strength for the involved versus the uninvolved side for: hip-
extension 142.2 Nm versus 152.9 Nm (p<0.05), knee-extension
104.7 Nm versus 117.4 Nm (p<0.001), knee-flexion 64.1 Nm
versus 67.4 Nm (p<0.05), and ankle-plantarflexion 63.3 Nm ver-
sus 67.6 Nm (p<0.05). The gait analysis showed biomechanical
changes in the involved versus the non-involved hip and knee.
Conclusions: The WOMAC showed a clinically acceptable state
for pain and physical function among the studied patients,
however, the patients showed significantly decreased muscle
strength for hip extension, knee extension and flexion, and an-
kle plantar flexion. Decreased muscle strength is a significant
risk factor for the development of knee OA and should there-
fore be targeted in these subjects. Both a randomized controlled
trial, regarding the effect of exercise therapy, and a case-control
study, identifying biomechanical and clinical characteristics, are
ongoing.
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Purpose: Research supports that the direct activation of the
Beta-Endorphinergic Systems (BES)could successfully decrease
the level of pain experienced. The "NEXALIN" design uses a
proprietary wave form (US Patent 6,904,322 B2), based on
a quasi resonance frequency of 77.5 Hz. This frequency was
confirmed in many prior Russian trials and studies, as being key
to stimulating the increase in concentration of beta-endorphins
in the brain, spinal fluid and blood (SU Patent #1522500). The
aim is to prove the possibility of decreasing pain caused by
osteoarthritis (OA) by using transcranial electrostimulation (TES)
via the "NEXALIN" device.
Methods: The study was multi-centered, randomized, double-
blind, and placebo-controlled. The study population consisted of
211 patients who had been diagnosed with OA of knee and/or
hip, had a pain history of at least three months, and scored 4 or
more on the Visual Score for Pain Assessment. The "NEXALIN"
groups received 7 daily TES session of 40 minutes, 15 mA (root
mean square); the placebo group received no stimulation using
a visually identical device. Assessment methods: pain level (PL),
patient global self-assessment (PGA), walking test (WT), physi-
cian’s assessment (PA) - all utilizing visual scales. Assessments
were performed prior to treatment, during the treatment series,
and at the 1 year follow-up assessment.
Results: After 7 treatments: PL decreased in the "NEXALIN"
group 57%, placebo 24% (p<10-9), WT 54% and 30% (P<10-
4); PGA and PA increased respectively 47% and 25% (P<0.04),
44% and 32% (P<0.03).
After 2 weeks: PL decreased in the "NEXALIN" group 40%,
placebo 21% (p<10-4), WT 42% and 30% (P<0.01); PGA and
PA increased respectively 29% and 25% (P<0.66), 42% and
30%(P<0.01).
Statically analysis also showed decreasing of PL in the "NEX-
ALIN" group during at least 6 weeks.
The number and type of side effects were equivalent in both
groups, with quantities in placebo exceeding active.
Conclusions: "NEXALIN’s" TES device, realized through activa-
tion of BES, provides significant and prolonged decrease in pain
associated with OA,
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Purpose: Chronic knee/hip pain, most commonly due to os-
teoarthritis (OA), is a leading cause of disability in the elderly.
Joint replacement is a cost-effective treatment option for ad-
vanced knee/hip OA. However, there is marked racial/ethnic
disparity in the utilization of joint replacement. The reasons for
this disparity remain poorly understood and might include dif-
ferential access to specialty care (rheumatology or orthopedic
